SAVED
File name .JPG
File alt. text
Image should be px wide x px tall.
Select Image
home - Pancreas - Pancreatic Cancers - Mucinous Cystadenoma Written by Dr Sebastian Zeki
Knowledge


Knows the presentation investigation and staging of pancreatic
cancer

Recognises the importance of considering and being able to identify
uncommon pancreatic tumours (such as neuroendocrine or
intrapapillary mucinous tuours)

Knows the range of potential therapies and recognises the factors
that make such tumours potentially operable or inoperable

Knows the prevalence and natural history of benign cysts/serous
cystadenoma and potentially malignant cystic lesions

Knows the options for palliative treatment
Skills
Shows ability to sequence investigations appropriately
Understands value of multi-disciplinary team
Recognises the importance of considering possibility that the tumour
is unusual

Behaviours
Communicates effectively within the multi-disciplinary team and with
the patient and their family

Mucinous Cystadenoma

Mucinous cystadenoma Mucin Mucin Mucin Macrocystic spaces lined by mucous-secreting cellsVery cellular collagenous and sometimes calcified stromal layer beneath epithelium with oestrogen/progesterone staining spindle cells EpidemiologyThey have a Malignant/ potential to be malignant.Middle aged woman are the most common patients.It is the Most common of the cystic neoplasms.Macrocystic spaces produce mucin within a mass is characteristic.It is Murderously difficult to make diagnosis from biopsy (cells often denuded).It is located in body or tail. Classification:-MCN with low-grade dysplasia.-MCN with moderate dysplasia.-MCN with high-grade dysplasia (which can be in situ or invasive- (17% of HGD and behaves as ductal adenocarcinoma). Categories are based on the degree of epithelial dysplasia. Written by Dr Sebastian Zeki

Related Stories

Pancreatic ductal adenocarcinoma, beta-blockers and antihistamines: A clinical trial is needed

Oncogenic cholesterol rewires lipid metabolism in hepatocellular carcinoma via the CSNK2A1-IGF2R Ser2484 axis

New Therapeutic Targets in RAS Wild-type Pancreatic Cancer

Comparative efficacy, toxicity, and insulin-suppressive effects of simvastatin and pravastatin in fatty acid-challenged mouse insulinoma MIN6 β-cell model

Survey of Experts' Opinions on the Diagnosis and Management of Pancreatic Cystic Neoplasms